Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

NCT02018055 - TALOS-AMI - Acetylsalicylic Acid (ASA) / Aspirin + Ticagrelor vs Aspirin + Clopidogrel & Acute Myocardial Infarction

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

In stabilized patients with acute myocardial infarction after index PCI, a uniform unguided de-escalation strategy significantly reduced the risk of net clinical events up to 12 months, mainly by reducing the bleeding events
Kim et al. 2021f The Lancet 398: 1305-1316…

References (Sources)

Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
Kim et al. 2021f The Lancet 398: 1305-1316

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

NCT02018055 - TALOS-AMI - Acetylsalicylic Acid (ASA) / Aspirin + Ticagrelor vs Aspirin + Clopidogrel & Acute Myocardial Infarction

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat

Links